Search

Your search keyword '"Li, Qingmei"' showing total 15 results
Start Over Author "Li, Qingmei" Publisher wiley
15 results on '"Li, Qingmei"'

2. Rice‐produced classical swine fever virus glycoprotein E2 with herringbone‐dimer design to enhance immune responses

Author

Xu, Qianru, primary, Ma, Fanshu, additional, Yang, Daichang, additional, Li, Qingmei, additional, Yan, Liming, additional, Ou, Jiquan, additional, Zhang, Longxian, additional, Liu, Yunchao, additional, Zhan, Quan, additional, Li, Rui, additional, Wei, Qiang, additional, Hu, Hui, additional, Wang, Yanan, additional, Li, Xueyang, additional, Zhang, Shenli, additional, Yang, Jifei, additional, Chai, Shujun, additional, Du, Yongkun, additional, Wang, Li, additional, Zhang, Erqin, additional, and Zhang, Gaiping, additional

Published
2023
Full Text
View/download PDF

4. A Noninvasive Delivery of DNA into Zygotes by AuNPs−PEI for Transgenic Mice

Author

Xiaoqing Wu, Yong Liu, Qiuyue Wang, Li Qingmei, Wenying Wang, Qi Wang, Fengrui Wu, Shuanglin Jiang, Hongli Qian, Fangfang Yu, Changfeng Dou, Xin Jing, Wei Fang, Xiaocui Cheng, Di Zhang, Wenyong Li, Huanhuan Li, and Rong Wang

Subjects
Genetically modified mouse, Zygote, Renewable Energy, Sustainability and the Environment, Transgene, Energy Engineering and Power Technology, Embryo, Cell biology, Green fluorescent protein, Biomaterials, chemistry.chemical_compound, chemistry, Colloidal gold, Materials Chemistry, DNA
Published
2020

5. Small Extracellular Vesicles: High‐Fidelity Determination and Tracing of Small Extracellular Vesicle Cargoes (Small 40/2020)

Author

Chen, Xiaohui, primary, Jia, Mei, additional, Liu, Lianhua, additional, Qiu, Xiaopei, additional, Zhang, Hong, additional, Yu, Xingle, additional, Gu, Wei, additional, Qing, Guangchao, additional, Li, Qingmei, additional, Hu, Xiaolin, additional, Wang, Ruixuan, additional, Zhao, Xianxian, additional, Zhang, Liangliang, additional, Wang, Xianfeng, additional, Durkan, Colm, additional, Wang, Nan, additional, Wang, Guixue, additional, and Luo, Yang, additional

Published
2020
Full Text
View/download PDF

6. High‐Fidelity Determination and Tracing of Small Extracellular Vesicle Cargoes

Author

Chen, Xiaohui, primary, Jia, Mei, additional, Liu, Lianhua, additional, Qiu, Xiaopei, additional, Zhang, Hong, additional, Yu, Xingle, additional, Gu, Wei, additional, Qing, Guangchao, additional, Li, Qingmei, additional, Hu, Xiaolin, additional, Wang, Ruixuan, additional, Zhao, Xianxian, additional, Zhang, Liangliang, additional, Wang, Xianfeng, additional, Durkan, Colm, additional, Wang, Nan, additional, Wang, Guixue, additional, and Luo, Yang, additional

Published
2020
Full Text
View/download PDF

8. A Noninvasive Delivery of DNA into Zygotes by AuNPs−PEI for Transgenic Mice

Author

Zhang, Di, primary, Wang, Qi, additional, Cheng, Xiaocui, additional, Li, Huanhuan, additional, Wang, Qiuyue, additional, Yu, Fangfang, additional, Wang, Wenying, additional, Xin, Jing, additional, Li, Qingmei, additional, Dou, Changfeng, additional, Wu, Xiaoqing, additional, Qian, Hongli, additional, Fang, Wei, additional, Wu, Fengrui, additional, Liu, Yong, additional, Jiang, Shuanglin, additional, Li, Wenyong, additional, and Wang, Rong, additional

Published
2020
Full Text
View/download PDF

14. Identification of the linear epitope for Fc‐binding on the bovine IgG2 Fc receptor (boFcγ2R) using synthetic peptides

Author

Zhang, Gaiping, primary, Guo, Junqing, additional, Zhou, Jiyong, additional, Wang, Xuannian, additional, Li, Qingmei, additional, Yang, Yanyan, additional, Shen, Huigang, additional, Zhao, Dong, additional, Zhang, Hua, additional, Xi, Jun, additional, Wang, Li, additional, Qiao, Songlin, additional, and Jin, Xin, additional

Published
2006
Full Text
View/download PDF

15. Clinical Evaluation of the Tolerability, Pharmacokinetics, and Inhibition of Platelet Aggregation of Eptifibatide in Healthy Chinese Subjects.

Author

Liu L, Ding Y, Jiao Z, Wu M, Li C, Liu J, Liu C, Hu Y, Li Q, and Zhang H

Subjects
Asian People ethnology, Body Mass Index, Eptifibatide administration & dosage, Eptifibatide adverse effects, Female, Half-Life, Healthy Volunteers, Humans, Infusions, Intravenous, Male, Platelet Aggregation Inhibitors administration & dosage, Platelet Aggregation Inhibitors adverse effects, Safety, Time Factors, Young Adult, Eptifibatide pharmacokinetics, Platelet Aggregation drug effects, Platelet Aggregation Inhibitors pharmacokinetics, Platelet Function Tests methods
Abstract

The present study aimed to evaluate the pharmacokinetic properties and antiplatelet aggregation activity of eptifibatide in healthy Chinese subjects. Eptifibatide (180 μg/kg) was administrated by 2 bolus injections 10 minutes apart, followed by a 2.0 μg/kg/min infusion for 24 hours. The eptifibatide pharmacokinetic and antiplatelet aggregation activities were evaluated using nonlinear mixed-effects modeling and noncompartmental analysis. Safety assessments included adverse events, hematology, and biochemistry tests. Twelve Chinese healthy subjects were enrolled and completed the study. Steady-state concentrations were achieved at 0.5 to 24 hours after dosing. The median time to maximum concentration was 13 minutes, and the mean terminal elimination half-life was 148.19 minutes. The effective inhibition of platelet aggregation (<20% platelet aggregation) occurred by 3 minutes after starting dosing to 4 hours after termination of the infusion. Eptifibatide concentrations were fitted with a 3-compartment model, and the typical value of clearance was 0.11 L/min, with no significant covariates found. Three mild adverse events were detected in the study. Eptifibatide displays high sensitivity and excellent tolerability in healthy Chinese subjects. The dosage of eptifibatide recommended on the label for whites can effectively inhibit platelet aggregation., (© 2019, The American College of Clinical Pharmacology.)

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results